Skip to content

Test and Treat TB: A Proof of Concept Trial in South Africa

Test and Treat TB: A Proof of Concept Trial in South Africa

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02298309
Acronym
Siyasiza
Enrollment
4815
Registered
2014-11-21
Start date
2015-04-30
Completion date
2017-11-30
Last updated
2018-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

TB, HIV, Test and Treat, Linkage

Brief summary

The purpose of this study is (1) to establish the feasibility, yield, and clinical impact of a Test & Treat TB strategy on a mobile HIV screening unit in South Africa and (2) to assess the cost and cost-effectiveness of this mobile, integrated HIV/TB screening strategy for maximizing linkage to TB care and treatment completion.

Interventions

OTHERTest-and-Treat TB

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
AIDS Healthcare Foundation
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English or Zulu speaking * presenting for screening at mobile unit * voluntarily undergoing HIV testing * able and willing to give informed consent * willing to share HIV and TB test results * willing to attend one of six local clinics for treatment * access to a mobile phone

Exclusion criteria

* pregnant

Design outcomes

Primary

MeasureTime frame
Number of patients who complete tuberculosis treatment6 months

Secondary

MeasureTime frameDescription
Proportion of eligible participants able to produce sputum samples20 months
Prevalence of TB among those tested20 months
Prevalence of tuberculosis and rifampin resistance20 monthsThe GeneXpert test can detect rifampin resistant strains of tuberculosis
Proportion of mobile testers screened for tuberculosis20 months
Proportion returning to the mobile tester for TB test result20 months
Linkage to TB care (first visit to a local TB treatment site ascertained from clinic record)1 month
ART initiation date as documented by clinic record for those HIV co-infected6 months
Distribution of TB symptoms ascertained from TB symptom screen questionnaire20 months

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026